Phase 2 clinical trial of DS-1211 begins for individuals with Pseudoxanthoma Elasticum

Biochemistry laboratory research, Scientist or medical in lab coat holding test tube with Using Microscope reagent with drop of color liquid over glass equipment working at the laboratory.

A Phase 2 clinical trial has started of DS-1211 in individuals with Pseudoxanthoma Elasticum (PXE), a rare multisystem genetic disease that causes calcium deposits in soft tissue resulting in considerable morbidity.

National study suggests new vaccine is needed to prevent childhood pneumonia

Previous article

Serbia vs Switzerland livestream options for 2022 FIFA World Cup

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News